In a strategic move to solidify its presence in the rapidly evolving metabolic health sector, Roche has announced an exclusive licensing agreement with Hanmi Pharmaceutical for the development and commercialization of HM17321, a clinical-stage investigational therapy designed to address obesity while preserving muscle mass. The agreement, executed through Roche’s Genentech subsidiary, involves an upfront payment […]
Cityblock, a leading value-based healthcare provider specializing in marginalized and complex patient populations, has announced the acquisition of Homeward Health in an all-stock transaction, alongside a successful $116 million Series E funding round. This strategic move marks a significant expansion for the New York-based company, allowing it to extend its integrated care model from urban […]
The financial burden of integrating artificial intelligence into clinical workflows has long been a primary hurdle for healthcare administrators, yet Cleveland Clinic appears to have cracked the code on proving the technology’s worth. By successfully onboarding more than 4,000 ambulatory care clinicians onto Ambience Healthcare’s ambient scribing platform in a mere four-month window, the world-renowned […]
Abcuro, a clinical-stage biotechnology company headquartered in Newton, Massachusetts, has announced the successful closing of a $66 million Series D financing round, a move intended to breathe new life into its lead program following mixed results in a pivotal clinical trial. The fresh capital is earmarked for the continued development of ulviprubart, a first-in-class monoclonal […]
The global healthcare landscape is currently undergoing a seismic shift as diagnostic testing moves out of the traditional laboratory setting and directly into the hands of the consumer. This transition, accelerated by the exigencies of the Covid-19 pandemic, has evolved from a temporary emergency measure into a permanent fixture of the modern medical infrastructure. According […]
Slate Medicines, a Raleigh-based biotechnology firm specializing in neurovascular disorders, has announced a definitive merger agreement with Nasdaq-listed Fulcrum Therapeutics. This strategic business combination serves as a pivotal moment for Slate, providing the company with a streamlined path to the public markets and a significant capital infusion to accelerate its pipeline of next-generation migraine treatments. […]
The Centers for Medicare & Medicaid Services (CMS) has officially launched a landmark financial initiative aimed at fortifying the nation’s rural healthcare infrastructure against the escalating threat of cyber warfare and operational instability. Through the Rural Health Transformation Program, the federal government is set to distribute $50 billion to states over a five-year period, with […]
Amylyx Pharmaceuticals has released topline results from its pivotal Phase 3 LUCIDITY clinical trial, demonstrating that its experimental drug avexitide significantly reduces the debilitating effects of post-bariatric hypoglycemia (PBH). The study’s primary endpoint was met with high statistical significance, showing that a once-daily administration of the drug reduced the frequency of hypoglycemia events by more […]
Across the United States, the integrity of federal and state-funded healthcare programs is facing an unprecedented challenge as Medicaid and Medicare fraud cases escalate in both frequency and financial magnitude. What were once viewed as isolated incidents of provider misconduct are now being recognized as a systemic vulnerability that threatens the long-term sustainability of the […]
The healthcare technology landscape faced a significant shift this week as Epic Systems, the nation’s dominant electronic health record (EHR) provider, convened its annual Users Group Meeting (UGM) at its sprawling headquarters in Verona, Wisconsin. The event, which typically serves as a showcase for the company’s latest software iterations and future-facing innovations, occurred under a […]
